Panelist Bios

Todd T. Brown, M.D., Ph.D.

Todd T. Brown, M.D., Ph.D., is a professor of medicine and epidemiology in the Division of Endocrinology, Diabetes, and Metabolism at Johns Hopkins University, where he also is the primary endocrine consultant to the Johns Hopkins HIV clinic. Dr. Brown is a graduate of the Columbia University Vagelos College of Physicians and Surgeons and the Johns Hopkins Bloomberg School of Public Health. He completed his clinical training at Georgetown University and Johns Hopkins University. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in people with HIV, particularly as they relate to aging. Dr. Brown serves as the co-chair of the Executive Committee of the Multicenter AIDS Cohort Study/Women’s Interagency HIV Study (or MACS/WIHS) Combined Cohort Study (MWCCS) and is co–principal investigator of the Baltimore/Washington site and the MWCCS Leadership and Coordination Center. He also has served in leadership positions on multiple clinical trials in the AIDS Clinical Trial Group examining the effects of antiretroviral therapies on metabolic, skeletal, and cardiovascular endpoints. Additionally, he has mentored many trainees from across the country and around the world in the area of HIV comorbidities and aging.

Steven G. Deeks, M.D.

Steven G. Deeks, M.D., is a professor of medicine at the University of California, San Francisco (UCSF). He is an expert on HIV and its effects on health while on antiretroviral therapy. Dr. Deeks is the principal investigator of the Delaney AIDS Research Enterprise (or DARE), an NIH-funded international collaboratory aimed at developing a cure for HIV infection. He directs the Study of the Consequences of the Protease Inhibitor Era (SCOPE) research program, which has supported hundreds of collaborative studies globally and more than 20 investigator-initiated clinical trials. In early 2020, Dr. Deeks and his team leveraged the SCOPE program to implement the Long-term Impact of Infection with Novel Coronavirus (or LIINC) study, one of the first prospective studies aimed at defining the natural history, biology, and treatment of Long COVID. Dr. Deeks has published more than 800 peer-reviewed articles. He was elected to The American Society for Clinical Investigation and the Association of American Physicians and serves on the scientific advisory board for Science Translational Medicine. In 2022, Dr. Deeks received the UCSF Lifetime Achievement in Mentoring Award. He also maintains a primary care clinic for people living with HIV.

Joseph Hwang, M.D., M.Sc.

Joseph Hwang, M.D., M.Sc., is an assistant professor of medicine at Johns Hopkins University. He is an internal medicine physician and pharmacoepidemiologist whose research focuses on evaluating the safety and effectiveness of medications using real-world data, with a particular focus on adults with HIV. Dr. Hwang received an NIH career development (or K) award to evaluate glucose-lowering therapies among people with HIV and type 2 diabetes. His research aims to generate population-specific evidence to inform the cardiometabolic care of adults with HIV.

Mariano Kanamori, Ph.D.

Mariano Kanamori, Ph.D., is the director of and a professor in the Division of Prevention Science and Community Health in the Department of Public Health Sciences at the University of Miami Miller School of Medicine. His research focuses on biomedical HIV prevention, substance use, and cancer. His work integrates implementation science, social network analysis, extended reality, and community-based participatory research to design and evaluate multilevel interventions. Dr. Kanamori has developed social network–based intervention models, including a spatially explicit framework that integrates multiple network types with geographic information systems.

George S. Kerr III

George S. Kerr III is a Washington, DC, community leader and HIV activist with 31 years of lived experience. As the community coordinator for the DC Center for AIDS Research (CFAR) at The George Washington University, Mr. Kerr serves as the liaison between the Community Partnership Council and research leadership, ensuring community voices shape the science. As chair of the National CFAR Community Action/Advisory Board Coalition, he connects community advisory boards across the country to advance HIV research priorities at a national scale. Mr. Kerr’s advocacy is personal, and his impact is proven.

Valeria Cantos Lucio, M.D.

Valeria Cantos Lucio, M.D., is an associate professor at the Division of Infectious Diseases at Emory University. She is the contact clinical research site (CRS) leader at the Emory Ponce CRS, where she conducts HIV prevention and HIV vaccine clinical trials. Dr. Cantos Lucio also focuses on implementation science projects to increase pre-exposure prophylaxis uptake among Latino gay and bisexual men. Clinically, Dr. Cantos cares for people living with HIV.

Keith Mintzer, Ph.D.

Keith Mintzer, Ph.D., has been working at the National Heart, Lung, and Blood Institute (NHLBI), within the National Institutes of Health, for 23 years. At NHLBI, Dr. Mintzer first served as a scientific review officer and now serves as a program officer in the Center for Translation Research and Implementation Science. His areas of interest include global implementation science, HIV comorbidities, extramural scientist and clinician training, and use of the arts to improve people’s health. Dr. Mintzer completed a Ph.D. in biology at Columbia University and conducted research in developmental genetics as an American Cancer Society Fellow at the University of Pennsylvania.

Marta Rodriguez-Garcia, M.D., Ph.D.

Marta Rodriguez-Garcia, M.D., Ph.D., is an associate professor at Wayne State University and the associate director for the Adult HIV Research Program. She completed postdoctoral training at the Ragon Institute of Mass General Brigham, Massachusetts Institute of Technology, and Harvard and at Dartmouth in mucosal and reproductive immunology. She joined Tufts University as an assistant professor in the Department of Immunology and later was recruited by Wayne State University as an associate professor in the Department of Biochemistry, Microbiology, and Immunology and the C.S Mott Center for Human Research and Development. Dr. Rodriguez-Garcia has consistently received awards and invitations to present her research at national and international conferences. She is an awardee of the Burroughs Wellcome Fund Investigators in the Investigators in the Pathogenesis of Infectious Disease (or PATH) program. She is the elected treasurer for the American Society of Reproductive Immunology and serves as an associate editor for Frontiers in Immunology and the American Journal of Reproductive Immunology. Dr. Rodriguez-Garcia’s research, funded by NIH and the Burroughs Wellcome Fund, focuses on understanding the early events of mucosal HIV acquisition in the female genital tract and how innate immune protection changes with age.

Stephanie Shiau, Ph.D., M.P.H.

Stephanie Shiau, Ph.D., M.P.H., is an associate professor in the Department of Biostatistics and Epidemiology at Rutgers School of Public Health, where she serves as the Epidemiology Concentration Leader. She earned a B.A. in public health studies from Johns Hopkins University and an M.P.H. and a Ph.D. in epidemiology from Columbia University, where she also completed a postdoctoral fellowship at the Gertrude H. Sergievsky Center. Dr. Shiau also is an alumna of the Sustained Training in Aging and HIV Research (or STAHR) scholars program at the University of California, San Diego.

Dr. Shiau’s research program sits at the intersection of life course epidemiology, infectious diseases, and aging. She studies how infectious diseases and related exposures during critical periods across the life course shape long-term health trajectories, multimorbidity, and healthy aging. To address these questions, Dr. Shiau applies epidemiologic and statistical methods to clinical, molecular, and real-world data in collaboration with interdisciplinary teams.

Dr. Shiau is committed to mentoring the next generation of scientists and fostering supportive research and learning environments. She serves as co-chair of the Mentoring Committee for the Society for Epidemiologic Research and completed the Mentoring the Mentors program at the University of California, San Francisco.